Study to Assess the Safety, Tolerability and Efficacy of Bilastine Ophthalmic Solution 0.6% in Children
Clinical trial NCT04810390 · COMPLETED
Trial details
- NCT number
- NCT04810390
- Sponsor
- Faes Farma, S.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-26
- Primary completion
- 2022-11-30
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.